The composition, apolipoprotein structure and lipoprotein binding to the LDL receptor were studied for very-low-density (VLDL) and low-density lipoprotein (LDL) particles isolated from subjects with apoE phenotype E3/3 (E3), E2/2 or E2/3 (E2+) and E3/4 or E4/4 (E4+) and a wide range of plasma triglyceride (TG) contents...
Keywords: apolipoprotein C-III, apolipoprotein E, low-density lipoprotein (LDL), low-density lipoprotein receptor, very-low-density lipoprotein (VLDL)
05/2005 | Biological Chemistry, Walter de GruyterActive anti-HIV therapy can induce hypertriglyceridemia, low high-density lipoprotein (HDL) and insulin resistance, eventually accompanied by clinical lipodystrophy, associated loss of subcutaneous adipose tissue and an increase in abdominal adiposity...
Keywords: antiretroviral therapy, apolipoprotein A-V, apolipoprotein C-III, apolipoprotein E, dyslipidemia, HIV, lipodystrophy, pharmacogenomics, protease inhibitors, tumor necrosis factor-? (TNF?)
07/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterThe apolipoprotein E (
Keywords: apolipoprotein E, denaturing HPLC, haplotyping, single-nucleotide polymorphism
05/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: apolipoprotein E, ischemic, lipoprotein lipase, Polymorphism, smoking
03/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter